ASCORBIC-ACID IN CHRONIC-SCHIZOPHRENICS UNDER NEUROLEPTIC LONG-TERM MEDICATION

被引：0

作者：

ZANDER, KJ ^{[1
]}

FEINBERG, SS ^{[1
]}

OPLER, LA ^{[1
]}

机构：

[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PSYCHIAT,BRONX,NY 10461

来源：

INTERNATIONAL JOURNAL OF NEUROSCIENCE | 1987年 / 32卷 / 1-2期

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：834 / 834

页数：1

共 50 条

[21] ELECTROENCEPHALOGRAPHIC CHANGES IN CHRONIC-SCHIZOPHRENICS UNDER CHEMOTHERAPY
BRUCK, MA
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 1958, 114 (10): : 945 - 945
[22] EFFECT OF FOLIC-ACID IN CHRONIC-SCHIZOPHRENICS
MULLEROVA, D
SIKORA, J
LIBIGER, J
NERAD, J
HASKOVEC, L
FILIP, V
[J]. ACTIVITAS NERVOSA SUPERIOR, 1975, 17 (04): : 222 - 225
[23] POSTURAL REFLEXES IN PATIENTS ON LONG-TERM NEUROLEPTIC MEDICATION
BECKLEY, DJ
BLOEM, BR
SINGH, J
REMLER, MP
WOLFE, NS
ROOS, RAC
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 1991, 93 (02) : 119 - 122
[24] LONG-TERM TREATMENT WITH NEUROLEPTICS IN CHRONIC SCHIZOPHRENICS
ECKMANN, F
[J]. PSYCHOPHARMACOLOGIA, 1972, 26 : 88 - &
[25] RATIONALIZING NEUROLEPTIC POLYPHARMACY IN CHRONIC-SCHIZOPHRENICS - EFFECTS OF CHANGING TO A SINGLE DEPOT PREPARATION
SONI, SD
SAMPATH, G
SHAH, A
KRSKA, J
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (05) : 354 - 359
[26] DO CHRONIC-SCHIZOPHRENICS IN HOSPITAL NEED MORE THAN ONE NEUROLEPTIC DRUG
RAO, VAR
COPPEN, A
[J]. BRITISH JOURNAL OF PSYCHIATRY, 1979, 134 (FEB) : 222 - &
[27] CRITERIA OF THE REHABILITATION PROCESS OF LONG STAY CHRONIC-SCHIZOPHRENICS
HUNZIKER, R
[J]. SOZIAL-UND PRAVENTIVMEDIZIN, 1987, 32 (03): : 144 - 149
[28] ASCORBIC-ACID ACTION IN NEUROLEPTIC-ASSOCIATED AMENORRHEA
KANOFSKY, JD
KAY, SR
LINDENMAYER, JP
SEIFTER, E
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1989, 9 (05) : 388 - 389
[29] EFFECT OF LONG-TERM INGESTION OF EXCESS ASCORBIC-ACID ON DRUG-METABOLIZING ENZYMES
PETERSON, FJ
BABISH, JG
RIVERS, JM
[J]. FEDERATION PROCEEDINGS, 1975, 34 (03) : 884 - 884
[30] ADVANTAGES AND DISADVANTAGES OF DEPOT-NEUROLEPTICS AS MAINTENANCE MEDICATION FOR CHRONIC-SCHIZOPHRENICS
MOLLER, HJ
KISSLING, W
[J]. CLINICAL NEUROPHARMACOLOGY, 1986, 9 : 259 - 262

← 1 2 3 4 5 →